Cleveland Clinic's First Biotech Company

Cleveland Clinic's first biotech company

The Cleveland Clinic has established its first biotech company, Cellect Therapeutics Inc., based on an antisense oligonucleotide conjugated with the enzyme activator 2-5A.

The Castle Group arranged a private placement of $5 million from qualified retail investors, and has

Read the full 437 word article

How to gain access

Continue reading with a
two-week free trial.